Westdeutsches Protonentherapiezentrum Essen gGmbH promotes public health and welfare as well as science and research by operating a proton therapy center at the University Hospital Essen site. The center operates four treatment rooms equipped with modern scanning technology and maintains a dedicated eye therapy position in treatment room 1. It treats primarily non‑respiratory tumors in the head/ear‑nose‑throat area, the spine, the prostate and pediatric tumors; the eye therapy position is used for choroidal melanomas, haemangiomas and iris melanomas. WPE has been in patient operation for ten years, is run by specialists experienced in proton therapy and is part of the West German Tumor Center of the University Hospital Essen.
Die Förderung der öffentlichen Gesundheits- und Wohlfahrtspflege sowie der Wissenschaft und Forschung durch den Betrieb von Einrichtungen ärztlicher Heilbehandlungen. Der Gesellschaftszweck wird insbesondere verwirklicht durch den Betrieb eines Protonentherapiezentrums am Standort des Universitätsklinikum Essen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 18903 (as of 31 October 2026)
| Name | Type | City |
|---|---|---|
| Angelika Eggert | Geschäftsführer(in) | Essen |
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 18903 (as of 31 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 01.06.2010 | Business Address Registered | Hufelandstr. 55, 45122 Essen |
| 12.12.2005 | Company Name Registered | Westdeutsches Protonentherapiezentrum Essen (WPE) gGmbH |
| 12.12.2005 | Registered Seat | Essen |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 12.12.2005 | Share Capital Set | — | 250.000 € |
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 18903 (as of 31 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€7.9M2 | -€7,373,099 | €102,771,957 | 116 |
| 2023 | Rohergebnis€7.7M2 | -€6,113,971 | €96,786,111 | 115 |
| 2022 | Rohergebnis€9.8M2 | -€2,415,850 | €93,364,671 | 113 |
| 2021 | Rohergebnis€8.4M2 | -€3,343,931 | €95,486,971 | 111 |
| 2020 | Rohergebnis€11.7M2 | -€4,108,682 | €93,688,047 | 122 |
| 2019 | Rohergebnis€18.2M2 | -€1,623,922 | €94,864,931 | 103 |
| 2018 | Rohergebnis€16.5M2 | -€3,326,201 | €96,398,199 | 92 |
| 2017 | Rohergebnis€13.3M2 | -€4,801,111 | €91,868,232 | 79 |
| 2016 | Rohergebnis€10.2M2 | -€7,274,840 | €97,803,485 | 86 |
| 2015 | Rohergebnis€7.8M2 | -€8,236,773 | €92,332,594 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Essen Local Court, HRB 18903 (as of 31 October 2026)
VITREA Rehaklinik Bad Ems GmbH
Bad Ems · Vorsorge- und Rehabilitationskliniken
TEAMPLAN-Gesellschaft für Planung und Organisation mbH
Tübingen · Vorsorge- und Rehabilitationskliniken
Bergman Deutsche Klinik Aschaffenburg GmbH
Aschaffenburg · Krankenhäuser (ohne Hochschulkliniken, Vorsorge- und Rehabilitationskliniken)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €6,136,349 | 49.0% |
| Depreciation | €2,291,764 | 18.3% |
| Interest & Similar | €4,103,781 | 32.7% |
